Jane Street
PSTV

Jane Street’s Plus Therapeutics PSTV Stock Holding History

Jane Street’s Portfolio PSTV Stock Details PSTV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-40,956
Closed -$525K – 12701
2025
Q4 		$525K Buy
+40,956
New +$618K ﹤0.01% 7567
2025
Q3 		– Sell
-4,698
Closed -$40.9K – 11558
2025
Q2 		$40.9K Buy
+4,698
New +$61.5K ﹤0.01% 9224
2018
Q1 		– Sell
-1
Closed -$52K – 5285
2017
Q4 		$52K Buy
+1
New +$70.1K ﹤0.01% 4424
2015
Q3 		– Hold
0
– -$34K – 4042
2015
Q2 		– Hold
0
– – – 3534
2014
Q1 		– Hold
0
– -$121K – 2987
2013
Q4 		– Hold
0
– – – 2152

Other funds holding PSTV

VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
TSS
Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Jane Street's PSTV Position: Q1 2026 in Review

Jane Street sold out of Plus Therapeutics (PSTV) in Q1 2026, closing a stake of 40,956 shares — an estimated $525K sold.

Jane Street first reported a position in PSTV in Q4 2017 and held it in 3 quarters. The position peaked at $525K in Q4 2025. 23 funds tracked by Wall St. Rank hold PSTV as of Q1 2026.

  • Jane Street reported no remaining Plus Therapeutics position as of Q1 2026 after selling out during the quarter.
  • Jane Street sold 40,956 Plus Therapeutics shares in Q1 2026, an estimated $525K.
  • Jane Street first reported a position in Plus Therapeutics in Q4 2017 and held it in 3 quarters.
  • Jane Street's Plus Therapeutics position peaked at $525K in Q4 2025.
  • 23 funds tracked by Wall St. Rank held Plus Therapeutics as of Q1 2026.

Based on Jane Street's 13F filing for Q1 2026, filed 12 May 2026.